AIMS/HYPOTHESIS: Evidence suggests that low serum potassium concentrations or hypokalaemia induced by the intake of diuretics are associated with incident diabetes and increased risk for diabetes in persons with hypertension. We examined a possible association between serum potassium and prediabetes (defined as isolated impaired fasting glucose [i-IFG], isolated impaired glucose tolerance [i-IGT] or combined IFG/IGT), as well as known and newly diagnosed diabetes (NDD), in 32- to 81-year-old men and women with and without hypertension. METHODS: This cross-sectional analysis was based on 2,948 participants in the Cooperative Health Research in the Region of Augsburg (KORA) F4 study conducted in 2006-2008 in southern Germany. Serum concentrations of potassium were measured by indirect potentiometry. RESULTS: In the total sample there was no association between serum potassium concentrations and prediabetes. In hypertensive persons however serum potassium levels in the first and second quartile compared with the highest quartile were independently significantly associated with prediabetes after multivariable adjustment (OR for prediabetes, 2.02 [95% CI 1.27, 3.21] for quartile 2 and 2.00 [95% CI 1.27, 3.15] for quartile 1), while in persons without hypertension no association was found. In multinomial logistic regression analysis these findings could be confirmed. In hypertensive participants after multivariable adjustment the associations were statistically significant for i-IGT and NDD (i-IGT OR 1.23; NDD OR 1.41). However, in non-hypertensive persons, all associations between serum potassium levels and each of the categories of impaired glucose regulation were non-significant. CONCLUSIONS/ INTERPRETATION: Serum potassium levels were independently associated with prediabetes and NDD in hypertensive adults from the general population.
AIMS/HYPOTHESIS: Evidence suggests that low serum potassium concentrations or hypokalaemia induced by the intake of diuretics are associated with incident diabetes and increased risk for diabetes in persons with hypertension. We examined a possible association between serum potassium and prediabetes (defined as isolated impaired fasting glucose [i-IFG], isolated impaired glucose tolerance [i-IGT] or combined IFG/IGT), as well as known and newly diagnosed diabetes (NDD), in 32- to 81-year-old men and women with and without hypertension. METHODS: This cross-sectional analysis was based on 2,948 participants in the Cooperative Health Research in the Region of Augsburg (KORA) F4 study conducted in 2006-2008 in southern Germany. Serum concentrations of potassium were measured by indirect potentiometry. RESULTS: In the total sample there was no association between serum potassium concentrations and prediabetes. In hypertensivepersons however serum potassium levels in the first and second quartile compared with the highest quartile were independently significantly associated with prediabetes after multivariable adjustment (OR for prediabetes, 2.02 [95% CI 1.27, 3.21] for quartile 2 and 2.00 [95% CI 1.27, 3.15] for quartile 1), while in persons without hypertension no association was found. In multinomial logistic regression analysis these findings could be confirmed. In hypertensiveparticipants after multivariable adjustment the associations were statistically significant for i-IGT and NDD (i-IGT OR 1.23; NDD OR 1.41). However, in non-hypertensivepersons, all associations between serum potassium levels and each of the categories of impaired glucose regulation were non-significant. CONCLUSIONS/ INTERPRETATION: Serum potassium levels were independently associated with prediabetes and NDD in hypertensive adults from the general population.
Authors: R Chatterjee; L A Colangelo; H C Yeh; C A Anderson; M L Daviglus; K Liu; F L Brancati Journal: Diabetologia Date: 2012-02-10 Impact factor: 10.122
Authors: Ranee Chatterjee; Mary L Biggs; Ian H de Boer; Frederick L Brancati; Laura P Svetkey; Joshua Barzilay; Luc Djoussé; Joachim H Ix; Jorge R Kizer; David S Siscovick; Dariush Mozaffarian; David Edelman; Kenneth J Mukamal Journal: J Gerontol A Biol Sci Med Sci Date: 2014-06-03 Impact factor: 6.053
Authors: Peggy Sekula; Oemer-Necmi Goek; Lydia Quaye; Clara Barrios; Andrew S Levey; Werner Römisch-Margl; Cristina Menni; Idil Yet; Christian Gieger; Lesley A Inker; Jerzy Adamski; Wolfram Gronwald; Thomas Illig; Katja Dettmer; Jan Krumsiek; Peter J Oefner; Ana M Valdes; Christa Meisinger; Josef Coresh; Tim D Spector; Robert P Mohney; Karsten Suhre; Gabi Kastenmüller; Anna Köttgen Journal: J Am Soc Nephrol Date: 2015-10-08 Impact factor: 10.121
Authors: Patrice Carter; Danielle H Bodicoat; Lauren M Quinn; Francesco Zaccardi; David R Webb; Kamlesh Khunti; Melanie J Davies Journal: J Diabetes Res Date: 2015-03-25 Impact factor: 4.011
Authors: Yutian Yin; Weiqing Han; Yuhan Wang; Yue Zhang; Shili Wu; Huiping Zhang; Lingling Jiang; Rui Wang; Peng Zhang; Yaqin Yu; Bo Li Journal: Int J Environ Res Public Health Date: 2015-10-12 Impact factor: 3.390
Authors: Ranee Chatterjee; Leila Zelnick; Kenneth J Mukamal; Jennifer A Nettleton; Bryan R Kestenbaum; David S Siscovick; Joachim H Ix; Russell Tracy; Andrew N Hoofnagle; Laura P Svetkey; David Edelman; Ian H de Boer Journal: PLoS One Date: 2016-06-09 Impact factor: 3.240
Authors: Rohit Babbar; Martin Heni; Andreas Peter; Martin Hrabě de Angelis; Hans-Ulrich Häring; Andreas Fritsche; Hubert Preissl; Bernhard Schölkopf; Róbert Wagner Journal: Front Endocrinol (Lausanne) Date: 2018-03-19 Impact factor: 5.555